Effects of m-chlorophenylpiperazine on receptor binding and brain metabolism of monoamines in rats

[1]  S. Garattini,et al.  (—)‐m‐Chlorophenyl‐piperazine, a central 5‐hydroxytryptamine agonist, is a metabolite of trazodone , 1981, The Journal of pharmacy and pharmacology.

[2]  S. Algeri,et al.  A Rapid and Simple Method for the Determination of Picogram Levels of 3‐Methoxytyramine in Brain Tissue Using Liquid Chromatography with Electrochemical Detection , 1981, Journal of neurochemistry.

[3]  R. Fuller,et al.  Disposition and pharmacological effects of m-Chlorophenylpiperazine in rats , 1981, Neuropharmacology.

[4]  L. Antkiewicz-Michaluk,et al.  5‐Hydroxytryptamine‐like properties of m‐chlorophenylpiperazine: comparison with quipazine , 1980, The Journal of pharmacy and pharmacology.

[5]  V. Crunelli,et al.  Effects of d- and 1-fenfluramine on striatal homovanillic acid concentrations in rats after pharmacological manipulation of brain serotonin. , 1980, Pharmacological research communications.

[6]  M. Tanaka,et al.  Simultaneous determination of noradrenaline and 3-methoxy-4-hydroxyphenylethyleneglycol sulfate in discrete brain regions of the rat. , 1979, Analytical biochemistry.

[7]  A. Herbet,et al.  Characteristics of central 5-HT receptors and their adaptive changes following intracerebral 5,7-dihydroxytryptamine administration in the rat. , 1978, Molecular pharmacology.

[8]  N. Nicolaou,et al.  THE INFLUENCE OF L‐TRYPTOPHAN AND MONOAMINE OXIDASE INHIBITORS ON CATECHOLAMINE METABOLISM IN RAT BRAIN , 1978, British journal of pharmacology.

[9]  J. Leysen,et al.  Spiperone: a ligand of choice for neuroleptic receptors. 1. Kinetics and characteristics of in vitro binding. , 1978, Biochemical pharmacology.

[10]  S. Snyder,et al.  3H-Spiroperidol labels dopamine receptors in pituitary and brain. , 1977, European journal of pharmacology.

[11]  R. Wightman,et al.  Liquid chromatographic monitoring of CSF metabolites , 1977, Brain Research.

[12]  B. Clineschmidt,et al.  Central serotonin-like activity of 6-chloro-2-[1-piperazinyl]-pyrazine (CPP; MK-212). , 1977, European journal of pharmacology.

[13]  Fuller Rw,et al.  Biphasic effects of m-chlorophenyl-piperazine on 3,4-dihydroxyphenylacetic acid concentration in rat brain. , 1977 .

[14]  A. Dray,et al.  Evidence for the existence of a raphe projection to the substantia nigra in rat , 1976, Brain Research.

[15]  S. Snyder,et al.  Beta adrenergic receptor binding in membrane preparations from mammalian brain. , 1976, Molecular pharmacology.

[16]  S. Snyder,et al.  Alpha-noradrenergic receptor binding in mammalian brain: differential labeling of agonist and antagonist states. , 1976, Life sciences.

[17]  S. Snyder,et al.  Serotonin and lysergic acid diethylamide binding in rat brain membranes: relationship to postsynaptic serotonin receptors. , 1976, Molecular pharmacology.

[18]  K. Fuxe,et al.  Effects of methergoline on central monoamine neurones. Evidence for a selective blockade of central 5-HT receptors , 1975, Neuroscience Letters.

[19]  S. Garattini,et al.  The serotonergic system in the brain and its possible functional connections with other aminergic systems. , 1975, Life sciences.

[20]  L. Valzelli,et al.  Biochemical aspects of the interaction between midbrain raphe and locus coeruleus in the rat. , 1974, Brain research.

[21]  J. Michaluk,et al.  The influence of quipazine on the turnover rate of serotonin. , 1974, Biochemical pharmacology.

[22]  K. Perry,et al.  Methiothepin elevation of 5-hydroxyindoleacetic acid levels in various anatomic regions of rat brain. , 1974, Brain research.

[23]  M. Jouvet,et al.  Biochemical evidences for interaction phenomena between noradrenergic and serotoninergic systems in the cat brain , 1974 .

[24]  A. Cools.  The transsynaptic relationship between dopamine and serotonin in the caudate nucleus of cats , 1974, Psychopharmacologia.

[25]  K Fuxe,et al.  Hallucinogenic phenylethylamines: interactions with serotonin turnover and receptors. , 1974, European journal of pharmacology.

[26]  R. Lisciani,et al.  Pharmacology of trazodone. , 1973, Current therapeutic research, clinical and experimental.

[27]  L. Valzelli,et al.  The effects of selective lesioning of brain serotonin or catecholamine containing neurones on the anorectic activity of fenfluramine and amphetamine. , 1972, European journal of pharmacology.

[28]  P. Carminati,et al.  Metaraminol and monoamineoxidase activity in the rat heart. , 1971, Research communications in chemical pathology and pharmacology.

[29]  B. Silvestrini,et al.  Pharmacological properties of AF 1161, a new psychotropic drug. , 1968, International journal of neuropharmacology.

[30]  L. Iversen,et al.  REGIONAL STUDIES OF CATECHOLAMINES IN THE RAT BRAIN‐I , 1966, Journal of neurochemistry.

[31]  C. Dunnett.  A Multiple Comparison Procedure for Comparing Several Treatments with a Control , 1955 .

[32]  M. Dixon.  The determination of enzyme inhibitor constants. , 1953, The Biochemical journal.

[33]  C. Bendotti,et al.  Further studies on the mechanism of serotonin-dependent anorexia in rats , 2004, Psychopharmacology.

[34]  S. Garattini,et al.  Biochemical pharmacology of the anorectic drug fenfluramine: a review , 1979 .

[35]  A. Dionisio,et al.  A controlled clinical study of a new antidepressant (trazodone). , 1971, Panminerva medica.